ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia

FHS
July 21, 2023
11:04 am

Trial to investigate the safety and efficacy of ARM210 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).

Sanofi faces $250M charge after J&J-partnered vaccine flunks late-stage test

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 14, 2025

Psychedelic Therapy Begins in Colorado, Amid Tension Between Conservatives, Veterans

As Colorado becomes the second state to legalize psychedelic therapy this week, a clash is playing out in Colorado Springs, where conservative leaders are restricting

January 3, 2025

Patent Filed by Eurofins Scientific SE for Cancer Detection Method with Cell-Free DNA

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. GlobalData Patent Analytics tracks bibliographic data,

April 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.